Drug | Reference |
---|---|
Acetazolamide | Wallace and Riegelmann (1977) |
Arbutine | Matsumoto et al. (1989) |
Bumetamide | Chang et al. (1988) |
Creatinine | Skalski et al. (1978) |
Darstine | Schanker et al. (1961) |
Desethyldorzolamide | Hasegawa et al. (1996) |
Digoxigenin digitoxoside | Hinderling (1984a) |
Digoxin-16′-glucuronide | Hinderling (1984a) |
Epinephrine | Schanker et al. (1961) |
Gentamycin | Lee et al. (1981a) |
Hippuric acid | Schanker et al. (1964) |
Metformin | Noel (1979) |
Tucker et al. (1981) | |
Norepinephrine | Schanker et al. (1961) |
p-Aminohippuric acid | Schanker et al. (1961) |
Papaverine | Garrett et al. (1978) |
Penicillin G | Kornguth and Kunin (1976) |
Matsumoto et al. (1989) | |
Phenol red | Schanker et al. (1964) |
Serotonin | Schanker et al. (1961) |
Sulfosalicylic acid | Schanker et al. (1964) |
Tacrolimus | Beysens et al. (1991) |
Tetracycline | Jun and Lee (1980) |
Tucaresol | Rolan et al. (1993) |
Vancomycin | Shin et al. (1992) |
↵5-a Time to 90% of equilibrium between red blood cells and plasma or buffer >30 seconds. Only drugs with significant red blood cell partitioning are considered.